Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth.

导出 OA

翻译打印收藏纠错

作者： Tal,Caller ^[1] ; Itai,Rotem ^[2] ; Olga,Shaihov-Teper ^[1] ; Daria,Lendengolts ^[2] ; Yeshai,Schary ^[1] ; Ruty,Shai ^[2] ; Efrat,Glick-Saar ^[1] ; Dan,Dominissini ^[2] ; Menachem,Motiei ^[1] ; Idan,Katzir ^[2] ; Rachela,Popovtzer ^[1] ; Merav,Nahmoud ^[3] ; Alex,Boomgarden ^[4] ; Crislyn,D'Souza-Schorey ^[4] ; Nili,Naftali-Shani ^[5] ; Jonathan,Leor ^[5]

作者单位： Neufeld and Tamman Cardiovascular Research Institutes, School of Medicine, Tel Aviv University, Israel (T.C., I.R., O.S.-T., D.L., Y.S., R.S., M.N., N.N.-S., J.L.). ^[1] Lev Leviev Cardiovascular and Thoracic Center (T.C., I.R., O.S.-T., D.L., Y.S., N.N.-S., J.L.), Sheba Medical Center, Tel Hashomer, Israel. ^[2] Pediatric Hemato-Oncology, Edmond and Lilly Safra Children's Hospital, Cancer Research Center (R.S.), Sheba Medical Center, Tel Hashomer, Israel. ^[3] Cancer Research Center and Wohl Centre for Translational Medicine (E.G.-S., D.D.), Sheba Medical Center, Tel Hashomer, Israel. ^[4] Faculty of Engineering, Bar-Ilan University, Ramat Gan, Israel (M.M., I.K., R.P.). ^[5] Department of Biological Sciences, University of Notre Dame, IN (A.B., C.D'S.-S.). ^[6]

关键词 cardio-oncology extracellular vesicles fibroblasts heart failure inflammation mesenchymal stem cells myocardial infarction neoplasms spironolactone